Atoltivimab Biosimilar
REQUEST MORE INFO
Catalogue No: abx831529
Price:
US$435.00
(Size: 100 µg)
Orders to United States ship from United States
(
Click on the image to see the image legend
Add to Cart
Buy It Now
GET A QUOTE
Documents
Datasheet SDS
Atoltivimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting Zaire Ebola Virus, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Atoltivimab can target Ebola virus and is expected to be used for post-exposure prevention of this deadly virus.
Research Articles on Zaire Ebola Virus
| Target | Zaire Ebola Virus |
| Research Area | Biosimilars |
| Clonality | Monoclonal |
| Reactivity | Human |
| Expression | Recombinant |
| Tested Applications | ELISA |
| Host | Human |
| Recommended dilutions | Optimal dilutions/concentrations should be determined by the end user. |
| Conjugation | Unconjugated |
| Isotype | IgG1 Kappa |
| Form | Liquid |
| Purity | > 95% |
| Purification | Purified from cell culture supernatants by Protein A/G chromatography. |
| Storage | Store at 4°C for up to 2 weeks. Aliquot and store at -20°C for long term storage. Avoid repeated freeze/thaw cycles. |
| Shelf Life | 12 months. |
| Buffer | 0.01 M PBS, pH 7.4. |
| CAS Number | 2135632-29-8 |
| Concentration | Batch-dependent, typically between 0.5-2.0 mg/ml. |
| Availability | Shipped within 5-10 working days. |
| Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |